Our preliminary analysis has revealed key insights about MICARE HEALTHTECH HOLDINGS (PTE. LTD.)'s performance and market presence. Here‘s a summary of our findings:
MICARE HEALTHTEC HOLDINGS
64202
Other holding companies
Other activities auxiliary to insurance and pension funding n.e.c. (e.g. activities of actuaries)
Recently transacted with MICARE HEALTHTECH HOLDINGS (PTE. LTD.)?
How would you rate your overall satisfaction?
Be a part of the community and help others make informed decisions by sharing your experience. Your feedback not only helps the business improve but also assists other customers in choosing the best services and products available.
This is only a preview of the TrustScore results for MICARE HEALTHTECH HOLDINGS (PTE. LTD.), showcasing a few facets of its business that we have analysed.
Established Stage
A established brand is one that has achieved a strong, recognisable presence in its market or industry. These brands are well-known, trusted and often considered as key brands in their space. They have a significant loyal customer base, a clear and consistent identity, and a proven track record of success and growth.
The company's address is not in use by other companies, providing a unique and credible business location. MICARE HEALTHTECH HOLDINGS (PTE. LTD.) is relatively new, having been operational for less than a year. Companies that have been established for a longer period of time are generally considered more reliable and trustworthy.
MICARE HEALTHTECH HOLDINGS (PTE. LTD.) has no presence on career platforms and provides no public information about its work environment or employee satisfaction. This lack of transparency may indicate less focus on employee well-being or difficulty in attracting talent, potentially impacting MICARE HEALTHTECH HOLDINGS (PTE. LTD.)'s long-term success.
The company is not blacklisted by CaseTrust, which is a positive indicator of its credibility. The company is not on the MAS Enforcement List, which is a positive indicator of its compliance with financial regulations.
MICARE HEALTHTECH HOLDINGS (PTE. LTD.) may not have accessible contact information online, which dilutes engagement and credibility. The company has no official business profile on major search engines. This absence makes it difficult for potential customers to verify the company's legitimacy or get in touch, potentially raising suspicions about its credibility.
Sign in to view the analysis and detailed metrics for MICARE HEALTHTECH HOLDINGS (PTE. LTD.)
Sign In to ContinueMiCare HealthTEC Holdings Pte Ltd ("MiCare"), a subsidiary of Zuellig Pharma and a leading medical claims administrator in the region, has announced that the International Finance Corporation (IFC), a member of the World Bank Group, and Mitsui & Co. (Asia Pacific) Pte. Ltd. ("Mitsui"), a subsidiary of Mitsui & Co, will be investing c.US$60 million in the company. Zuellig Pharma will remain as MiCare's largest shareholder and MiCare will continue to be led by its Founder and Group CEO, Moses Hee. The strategic investment will be used to fund MiCare's expansion in key Southeast Asian markets including Indonesia and Vietnam as well as to set up a new regional headquarters in Singapore. Baker McKenzie were the appointed legal advisors for this investment deal. MiCare is a managed care organisation ("MCO") that administers, processes and manages medical claims of policyholders and members on behalf of insurance companies and self-insured corporate clients. The company also builds applications linking key players in the healthcare sector such as doctors, patients, hospitals, clinics and pharmacies, to facilitate the seamless and efficient management of medical claims. MiCare has more than 13 million members in three countries – Malaysia, Thailand and the Philippines – and is looking to continue to grow and expand in the region.
MiCare HealthTEC Holdings Pte Ltd, a subsidiary of Zuellig Pharma and a leading medical claims administrator in the region, has announced that the International Finance Corporation (IFC), a member of the World Bank Group, and Mitsui & Co. (Asia Pacific) Pte. Ltd., a subsidiary of Mitsui & Co, will be investing c.US$60 million in the company. Zuellig Pharma will remain as MiCare’s largest shareholder and MiCare will continue to be led by its Founder and Group CEO, Moses Hee. The strategic investment will be used to fund MiCare’s expansion in key Southeast Asian markets including Indonesia and Vietnam as well as to set up a new regional headquarters in Singapore. Baker McKenzie were the appointed legal advisors for this investment deal. MiCare is a managed care organisation (“MCO”) that administers, processes and manages medical claims of policyholders and members on behalf of insurance companies and self-insured corporate clients. The company also builds applications linking key players in the healthcare sector such as doctors, patients, hospitals, clinics and pharmacies, to facilitate the seamless and efficient management of medical claims. MiCare has more than 13 million members in three countries – Malaysia, Thailand and the Philippines – and is looking to continue to grow and expand in the region.
Have questions? We’re here to help you.
Scam.SG's TrustScore is an AI-driven engine that evaluates a business's trustworthiness by analysing data such as customer feedback, behavioral patterns, and compliance records. This comprehensive assessment results in a numerical score reflecting the entity's reliability.